Skip to main content

Posts

Soccer-Argentina beat Dutch in shootout to reach final

Argentina's Sergio Romero saved two penalties in a 4-2 shootout win over the Netherlands to seal their first World Cup final place in 24 years after the first ever goalless semi-final at the end of extra time on Wednesday. Romero plunged low to his left to save the first penalty kick from defender Ron Vlaar and then made a superb stop from Wesley Sneijder as Argentina's jubilant fans went wild at the Corinthians arena. The pressure of scoring the winning penalty kick fell to Argentina substitute Maxi Rodriguez who slotted high past Jasper Cillessen, with the Dutch keeper failing to emulate the heroics of backup Tim Krul in their quarter-final win over Costa Rica. Twice champions Argentina now travel to Rio de Janeiro for Sunday's final against old rivals Germany, who thrashed hosts Brazil 7-1 in the other semi-final in Belo Horizonte on Tuesday. It will be a repeat of the 1986 and 1990 finals and the first time the same two teams will have faced each other three times

Romero the hero as Argentina edge Dutch in shootout

Argentina's launched himself left and right to save two penalties in a 4-2 shootout win over the Netherlands on Wednesday that sealed the South Americans' first World Cup final appearance in 24 years. After the teams battled to a 0-0 draw in the first ever goalless semi-final, Romero plunged low to his left to save the first kick from Dutch defender Ron Vlaar, then flew high to his right to palm away Wesley Sneijder's effort. The pressure of scoring the winning penalty kick fell to Argentina substitute Maxi Rodriguez, who picked power over placement and, while Jasper Cillessen got a hand to the ball, it ricocheted up off the underside of the bar and into the net. Twice champions Argentina now travel to Rio de Janeiro for Sunday's final against old rivals Germany, who thrashed hosts Brazil 7-1 in the other semi-final in Belo Horizonte on Tuesday. It will be a repeat of the 1986 and 1990 finals and the first time the same two teams will have faced each other three t

Sterling lashes out at wife in trial over $2 bln Clippers sale

Los Angeles Clippers owner Donald Sterling lashed out at his estranged wife following her court testimony on Wednesday in a trial over the $2 billion sale of the NBA team. Sterling, 80, who is fighting to scuttle the deal his wife Shelly Sterling negotiated with former Microsoft Corp Chief Executive Officer Steve Ballmer, lashed out at his wife when she approached him after her testimony. "Get away from me, you pig!" Sterling growled, startling his wife who had said she moved to gain control of the family trust that owns the Clippers out of concern for his mental health. "Shelly, how could you lie?" the real estate billionaire added before apologizing to Judge Michael Levanas for disturbing court. Shelly Sterling, 79, last month asked Los Angeles Superior Court to confirm her as having sole authority to sell the professional basketball franchise after her husband vowed to block the NBA-record sale. Donald Sterling was banned for life by the NBA in April for p

Merck nausea drug works in children in late-stage trial

Merck & Co Inc said its drug for treating chemotherapy-induced nausea and vomiting, Emend, was shown to be more effective than a placebo in a late-stage trial in children. _0"> The company said it plans to file for marketing approval for Emend in the U.S. for the new pediatric formulation in the second half of 2014. Merck said 51 percent of patients getting Emend showed no vomiting, no retching and no use of rescue medication for nausea and vomiting 25 to 120 hours following the beginning of chemotherapy, compared to 26 percent of those on a placebo. More than 70 percent of cancer patients undergoing chemotherapy suffer from nausea and vomiting that may result in a delay or discontinuation of treatment. Prolonged nausea and vomiting can also lead to weight loss, dehydration and malnutrition. Emend is already approved for treating chemotherapy-induced nausea and vomiting in adults and had global sales of $507 million in 2013. Tesaro Inc's experimental drug Rolapi

Modi pitches India's frugal space prowess at rocket launch

Newly elected Prime Minister Narendra Modi made a pitch for India to be the world's low-cost space technology supplier after witnessing the launch of a rocket carrying five satellites from France, Singapore, Germany and Canada on Monday. The Polar Satellite Launch Vehicle's mission bolstered India's goal of capturing a large slice of the global satellite launch industry, estimated to be worth around $55 billion over the next decade. Deviprasad Karnik, spokesman for the Indian Space Research Organization, said all five satellites had been placed in orbit. Modi said India's space program put it in an "elite global group of five-six countries today. This is one domain in which we are at the international cutting edge, a domain in which we have pushed beyond mediocrity to achieve excellence." So far, India has launched 40 satellites for 19 countries, many of them advanced nations. Although that is a source of pride for Modi, the nationalist leader underscore

Deep frozen testicle tissue used to produce babies in mice

Scientists have for the first time produced live offspring from testicle tissue that has been cryopreserved, or deep frozen, and say a similar technique might one day be used to preserve the fertility of boys facing cancer treatment. _0"> In a study published in the journal Nature Communications on Tuesday, Japanese researchers said their experiments using mice led to eight healthy offspring being born from sperm produced by previously frozen and thawed testicle tissue. "The cryopreservation of testicle tissue may be a realistic measure for preserving fertility," the team, led by Takehiko Ogawa of Japan's Yokohama City University Association of Medical Science, wrote in the study. Infertility is one of the adverse side effects of certain types of cancer treatment, and, as cure rates for childhood cancers are increasing, fertility has become an important concern for patients and their families. Freezing sperm itself to preserve it for future use is only possi

Nature journal retracts stem cell paper citing 'critical errors'

A stem cell paper published by a team of Japanese and American scientists in the influential journal Nature has been retracted due to "several critical errors", the journal said on Wednesday. The research, which when published in January was described as game-changing by many experts in the field, was subsequently investigated by Japan's RIKEN scientific institute, which "categorised some of the errors as misconduct", Nature said. The paper, led at RIKEN by Japanese researcher Haruko Obokata, detailed simple ways to reprogram mature animal cells back to an embryonic-like state, allowing them to generate many different types of cells. The results appeared to offer a promise that human cells might in future be simply and cheaply reprogrammed into embryonic-like cells - in this case cells dubbed Stimulus-Triggered Acquisition of Pluripotency, or STAP, cells - suggesting a simple way to replace damaged cells or grow new organs for sick and injured people. Obok